Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients

Neil L. Berinstein, Mohan Karkada, Amit M. Oza, Kunle Odunsi, Jeannine Villella, John Nemunaitis, Michael A. Morse, Tanja Pejović, J. Bentley, Marc Buyse,

OncoImmunology · 2015 · 99 citations · 28 references

DOIFull text

Open access

Concepts

Abstract

T cells and provided a strong rationale for further testing to determine clinical benefits associated with this immune activation. These data represent vaccine-induced T cell activation in a clinical setting to a self-tumor antigen previously described only in animal models.

References

28